STADA

Press Releases

Press Releases

STADA Arzneimittel AG is to execute a share split

Bad Vilbel, September 26, 2000 - STADA Arzneimittel AG of Bad Vilbel near Frankfurt is to execute a share split. On October 2, 2000, both common shares (securities identification number 725180) and preferred shares (securities identification number 725183) will be split 1:10. The share split had already been approved at the Annual General Meeting held June 19, 2000 and has now been entered into the commercial register. Since all technical requirements are fulfilled, the management can proceed with the share split at the beginning of the fourth quarter. STADA's shares are listed on the S-MAX segment of the German stock exchange.

The share split also affects the STADA warrants (securities identification numbers 725184 and 725185). After the share split, there will be 10 shares for each warrant when the option is exercised.

Hartmut Retzlaff, CEO of STADA Arzneimittel AG, comments: "It is well known that STADA boasts excellent fundamentals. For fiscal 2000 we are looking at the fifth record year in a row in terms of both sales and earnings. The share split is designed to support trading and to create the best possible technical framework conditions for the future performance of our shares".

For more information, please contact:

STADA Arzneimittel AG
Corporate Communications
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Learn more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken